AstraZeneca Builds Cambridge R&D Headquarters

AstraZeneca is building the £750 million Global R&D Centre and Corporate Headquarters on the Cambridge Biomedical Campus in the United Kingdom. Providing advanced facilities for pharmaceutical discovery and development, the 580,000-sf project will include space for biologics research, high throughput screening, medicinal chemistry, pre-clinical research, and clinical studies. Designed to optimize interaction and connectivity, the collaborative 11-acre campus will accommodate approximately 2,000 employees and will include an on-site energy center. BREAM Excellent sustainable design certification will be sought for the project, which will feature green roofs and the largest ground source heat pump in Europe. The design architect is Herzog & de Meuron and the construction manager is Skanska. Ground was broken on the project in spring of 2015 with completion expected in 2021.